Sponsor Deadline
Posted: 2/15/2023

Request for Proposals (RFP): Immunotherapy in Urothelial Carcinoma

Pfizer Global Medical Grants (GMG), and Merck KGaA, Darmstadt, Germany – Global Medical Unit Oncology are collaborating to provide grant support for continuing professional education in the area of Immuno-Oncology.  Immuno-Oncology is a top priority for Merck KGaA, Darmstadt, Germany and Pfizer Inc, and for the Global Strategic Alliance between our organizations.

The intent of this RFP is to support independent education initiatives for healthcare professionals involved in the treatment of patients with locally advanced or metastatic urothelial carcinoma (mUC), including oncologists, urologists, and specialty nurses.   

The goal is to increase understanding of treatment options in the 1st line and 2nd line setting, including 1st line maintenance treatment, for locally-advanced or metastatic urothelial carcinoma.  To include: • The differences between upfront treatment, sequencing strategies, and  second-line treatment in mUC • Role of chemotherapy in mUC and criteria to define platinum eligibility • Assessing the evidence for maintenance regimens in 1L mUC  • Identification of patients who may be eligible for maintenance treatment • The appropriate duration for maintenance treatment in 1L mUC  • Safety and management of available UC treatment options including IO ADC safety profile • Current practices and evidence for therapy options in first and secondline treatment and the factors which influence treatment decisions • Integrating support and patient communication via the whole care team during treatment 

UPDATED Grant application due date: March 31, 2023 (was February 23, 2023)

Eligibility Requirements

Geographic Scope:

• Europe

• Asia

• Latin America

• Canada

• Global: applications for this RFP must have a European or Asian or Latin American focus, however if a program also has a broader global reach it would be welcomed and encouraged. 

The following may apply: professional associations and medical societies ; medical, nursing, allied health, and/or pharmacy professional schools; healthcare institutions (both large and small); patient advocacy groups; medical education companies; other entities with a mission related to healthcare professional education and/or healthcare improvement.

If the project involves multiple institutions / organizations / associations all institutions must have a relevant role and the requesting organization must have a key role in the project.

Amount Description

The total available budget related to this RFP is approximately $1,000,000 USD.  The typical grant maximum under this RFP will be up to $250,000 USD for initiatives with large potential reach and impact. 

Amount
$250,000
Funding Type
Eligibility
Posted
2/15/2023
Deadline
Sponsor: